- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
-
- 长期趋势：
已有396家主力机构披露2024-06-30报告期持股数据，持仓量总计10.72亿股，占流通A股55.49%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了95%的股票
技术面评分前10的股票
近期的平均成本为22.06元。
平均成本
近期的平均成本为22.06元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"22.06","date":1732178627,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2024.11.22","stock":"-1.68","trade":"-4.07","ind":"-3.06"},{"date":"2024.11.21","stock":"0.55","trade":"-0.18","ind":"0.07"},{"date":"2024.11.20","stock":"4.97","trade":"2.34","ind":"0.66"},{"date":"2024.11.19","stock":"0.97","trade":"0.64","ind":"0.67"},{"date":"2024.11.18","stock":"0.53","trade":"-0.65","ind":"-0.21"},{"date":"2024.11.15","stock":"-2.32","trade":"-2.29","ind":"-1.45"},{"date":"2024.11.14","stock":"0.86","trade":"-3.87","ind":"-1.73"},{"date":"2024.11.13","stock":"-1.09","trade":"-1.73","ind":"0.51"},{"date":"2024.11.12","stock":"3.98","trade":"5.16","ind":"-1.39"},{"date":"2024.11.11","stock":"2.68","trade":"0.99","ind":"0.51"},{"date":"2024.11.08","stock":"-1.00","trade":"-1.13","ind":"-0.53"},{"date":"2024.11.07","stock":"2.41","trade":"2.85","ind":"2.57"},{"date":"2024.11.06","stock":"-0.81","trade":"0.28","ind":"-0.09"},{"date":"2024.11.05","stock":"0.56","trade":"1.11","ind":"2.32"},{"date":"2024.11.04","stock":"0.20","trade":"2.16","ind":"1.17"},{"date":"2024.11.01","stock":"0.98","trade":"3.44","ind":"-0.24"},{"date":"2024.10.31","stock":"-1.28","trade":"0.60","ind":"0.42"},{"date":"2024.10.30","stock":"-4.34","trade":"-0.40","ind":"-0.61"},{"date":"2024.10.29","stock":"-1.68","trade":"-2.99","ind":"-1.08"},{"date":"2024.10.28","stock":"-0.43","trade":"2.25","ind":"0.68"},{"date":"2024.10.25","stock":"0.24","trade":"1.75","ind":"0.59"}]
上海医药,上证指数,医药商业指数
压力支撑
该股压力位为22.00元，支撑位为21.55元。
[{"text":"\u538b\u529b\u4f4d","value":"22.00","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"21.55","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.6资金面打败了86%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月22日 17:11
| 机构今日流向(万元) | -3793.62 | 机构5日流向(万元) | -5417.89 |
| 机构10日流向(万元) | -20931.08 | 机构20日流向(万元) | -32398.34 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加8666.22万股，其中基金净减仓23家，主力净增仓10家，请投资者中长期谨慎为宜。
截止2024-06-30，共396家主力机构（基金392家，保险公司1家，一般法人3家），持仓量总计107197.03万股，占流通A股55.49%
其中，基金持仓与2023-12-31相比：
增仓：98家 ，增持 2261.06万股
减仓：121家 ，减持 1807.22万股
新出现在主力名单中：155家 ，持有11308.96万股
从主力名单中消失：145家 ，原持有2452.79万股
其中，基金持仓与2023-12-31相比：
增仓：98家 ，增持 2261.06万股
减仓：121家 ，减持 1807.22万股
新出现在主力名单中：155家 ，持有11308.96万股
从主力名单中消失：145家 ，原持有2452.79万股
消息面诊股
诊断结果：5.8消息面打败了66%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 砍管线是医药行业集约化发展特色？不少药企正在经历管
2024-11-22 - 上海医药：11月21日获融资买入4501.89万元
2024-11-22 - 【华安医药】公募基金医药板块2024Q3持仓分析：
2024-11-21 - 大险资同日举牌2家头部药企、医保局表态数据赋能商保
2024-11-21 - “长钱”来了，险资密集举牌上市公司，这些板块受追捧
2024-11-21 - 上海医药：11月20日获融资买入6435.42万元
2024-11-21 - 险资密集举牌红利股
2024-11-21 - 多只医药股被险资举牌！“牛散”钟格、魏巍等出手，已
2024-11-20 - 险资举牌潮涌，年内扫货16家上市公司，看中哪些资产
2024-11-20 - 年内险企已举牌十五次
2024-11-20
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2024-10-30 |
| 利好 | 分红转增 | 10派0.8元(含税) | 2024-08-27 |
| 一般消息 | 高管变动 | 因工作调动 | 2024-08-05 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2024-06-29 |
| 一般消息 | 股东大会 | 年度股东大会 | 2024-06-07 |
| 一般消息 | 高管变动 | 因工作调整 | 2024-05-27 |
| 利好 | 分红转增 | 10派4.1元(含税) | 2024-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-03-29 |
| 一般消息 | 高管变动 | 因工作调动 | 2024-03-19 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2023-12-22 |
| 一般消息 | 高管变动 | 工作调整 | 2023-12-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2023-12-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.2行业面打败了82%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2024.11.22","price":"-3.06","value":"-4.07"},{"date":"2024.11.21","price":"0.07","value":"-0.18"},{"date":"2024.11.20","price":"0.66","value":"2.34"},{"date":"2024.11.19","price":"0.67","value":"0.64"},{"date":"2024.11.18","price":"-0.21","value":"-0.65"},{"date":"2024.11.15","price":"-1.45","value":"-2.29"},{"date":"2024.11.14","price":"-1.73","value":"-3.87"},{"date":"2024.11.13","price":"0.51","value":"-1.73"},{"date":"2024.11.12","price":"-1.39","value":"5.16"},{"date":"2024.11.11","price":"0.51","value":"0.99"},{"date":"2024.11.08","price":"-0.53","value":"-1.13"},{"date":"2024.11.07","price":"2.57","value":"2.85"},{"date":"2024.11.06","price":"-0.09","value":"0.28"},{"date":"2024.11.05","price":"2.32","value":"1.11"},{"date":"2024.11.04","price":"1.17","value":"2.16"},{"date":"2024.11.01","price":"-0.24","value":"3.44"},{"date":"2024.10.31","price":"0.42","value":"0.60"},{"date":"2024.10.30","price":"-0.61","value":"-0.40"},{"date":"2024.10.29","price":"-1.08","value":"-2.99"},{"date":"2024.10.28","price":"0.68","value":"2.25"},{"date":"2024.10.25","price":"0.59","value":"1.75"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 健之佳 | 18.88% | 3.73% | 5.0分 |
| 2 | 药易购 | 14.73% | -12.70% | 3.9分 |
| 3 | 塞力医疗 | 13.09% | 0.00% | 4.2分 |
| 4 | 漱玉平民 | 11.73% | -3.61% | 3.8分 |
| 5 | 国药股份 | 10.41% | 2.16% | 5.1分 |
| 6 | 人民同泰 | 10.40% | -2.54% | 4.5分 |
| 8 | 第一医药 | 9.64% | -4.77% | 4.1分 |
| 10 | 嘉事堂 | 6.74% | 2.94% | 4.3分 |
| 12 | 老百姓 | 4.14% | -2.87% | 4.7分 |
| 14 | 上海医药 | 3.68% | 5.34% | 5.7分 |
| 16 | 柳药集团 | 3.39% | 0.33% | 4.6分 |
| 18 | 大参林 | 2.34% | -4.49% | 4.8分 |
| 20 | 合富中国 | 1.45% | -3.85% | 3.8分 |
| 22 | 瑞康医药 | 0.96% | 1.95% | 3.9分 |
| 24 | 浙江震元 | -1.10% | -0.25% | 4.2分 |
| 26 | 一心堂 | -2.09% | -4.57% | 3.9分 |
| 28 | 开开实业 | -6.34% | -5.25% | 4.0分 |
| 30 | 达嘉维康 | -8.86% | -2.10% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 14/71 ， 18/71。
[{"date":"2024-09-30","value":"5.82","vol":"5.85"},{"date":"2024-06-30","value":"4.25","vol":"4.44"},{"date":"2024-03-31","value":"2.23","vol":"2.30"},{"date":"2023-12-31","value":"5.56","vol":"7.23"},{"date":"2023-09-30","value":"5.60","vol":"7.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.82 | 4.25 | 2.23 | 5.56 | 5.60 |
| 行业(%) | 5.85 | 4.44 | 2.30 | 7.23 | 7.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"11.06","vol":"17.89"},{"date":"2024-06-30","value":"11.60","vol":"17.84"},{"date":"2024-03-31","value":"11.44","vol":"17.80"},{"date":"2023-12-31","value":"12.04","vol":"17.83"},{"date":"2023-09-30","value":"12.13","vol":"18.09"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
11.06 | 11.60 | 11.44 | 12.04 | 12.13 |
| 行业(%) | 17.89 | 17.84 | 17.80 | 17.83 | 18.09 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/71 ， 9/71。
[{"date":"2024-09-30","value":"6.14","vol":"2.06"},{"date":"2024-06-30","value":"5.14","vol":"1.88"},{"date":"2024-03-31","value":"5.93","vol":"4.80"},{"date":"2023-12-31","value":"12.21","vol":"4.27"},{"date":"2023-09-30","value":"13.11","vol":"6.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.14 | 5.14 | 5.93 | 12.21 | 13.11 |
| 行业(%) | 2.06 | 1.88 | 4.80 | 4.27 | 6.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"6.78","vol":"-50.40"},{"date":"2024-06-30","value":"12.72","vol":"-17.67"},{"date":"2024-03-31","value":"1.62","vol":"3.54"},{"date":"2023-12-31","value":"-32.92","vol":"2.19"},{"date":"2023-09-30","value":"-21.13","vol":"10.40"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
6.78 | 12.72 | 1.62 | -32.92 | -21.13 |
| 行业(%) | -50.40 | -17.67 | 3.54 | 2.19 | 10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 11/71 ， 16/71。
[{"date":"2024-09-30","value":"0.96","vol":"0.89"},{"date":"2024-06-30","value":"0.64","vol":"0.60"},{"date":"2024-03-31","value":"0.33","vol":"0.31"},{"date":"2023-12-31","value":"1.27","vol":"1.24"},{"date":"2023-09-30","value":"0.96","vol":"0.91"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.96 | 0.64 | 0.33 | 1.27 | 0.96 |
| 行业(次) | 0.89 | 0.60 | 0.31 | 1.24 | 0.91 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"5.03","vol":"4.52"},{"date":"2024-06-30","value":"3.43","vol":"3.08"},{"date":"2024-03-31","value":"1.76","vol":"1.58"},{"date":"2023-12-31","value":"6.44","vol":"6.32"},{"date":"2023-09-30","value":"4.99","vol":"4.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
5.03 | 3.43 | 1.76 | 6.44 | 4.99 |
| 行业(次) | 4.52 | 3.08 | 1.58 | 6.32 | 4.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"3.23","vol":"4.01"},{"date":"2024-06-30","value":"8.65","vol":"6.46"},{"date":"2024-03-31","value":"-7.80","vol":"-3.83"},{"date":"2023-12-31","value":"4.67","vol":"10.23"},{"date":"2023-09-30","value":"1.02","vol":"2.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.23 | 8.65 | -7.80 | 4.67 | 1.02 |
| 行业 | 4.01 | 6.46 | -3.83 | 10.23 | 2.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.12","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.25","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.12 | - | 1.25 | - |
| 行业 | 0.00 | 0.77 | 0.00 | 1.02 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/71 ， 3/71。
[{"date":"2024-09-30","value":"1.34","vol":"1.47"},{"date":"2024-06-30","value":"1.33","vol":"1.49"},{"date":"2024-03-31","value":"1.34","vol":"1.51"},{"date":"2023-12-31","value":"1.33","vol":"1.51"},{"date":"2023-09-30","value":"1.34","vol":"1.48"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.34 | 1.33 | 1.34 | 1.33 | 1.34 |
| 行业 | 1.47 | 1.49 | 1.51 | 1.51 | 1.48 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.02","vol":"1.04"},{"date":"2024-06-30","value":"1.02","vol":"1.06"},{"date":"2024-03-31","value":"1.00","vol":"1.09"},{"date":"2023-12-31","value":"0.99","vol":"1.07"},{"date":"2023-09-30","value":"1.00","vol":"1.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.02 | 1.02 | 1.00 | 0.99 | 1.00 |
| 行业 | 1.04 | 1.06 | 1.09 | 1.07 | 1.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 15/71 ， 13/71。
[{"date":"2024-09-30","value":"62.83","vol":"61.64"},{"date":"2024-06-30","value":"62.85","vol":"61.18"},{"date":"2024-03-31","value":"62.25","vol":"61.00"},{"date":"2023-12-31","value":"62.11","vol":"60.66"},{"date":"2023-09-30","value":"62.40","vol":"61.05"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
62.83 | 62.85 | 62.25 | 62.11 | 62.40 |
| 行业(%) | 61.64 | 61.18 | 61.00 | 60.66 | 61.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.98","vol":"2.19"},{"date":"2024-06-30","value":"1.99","vol":"2.15"},{"date":"2024-03-31","value":"1.93","vol":"2.15"},{"date":"2023-12-31","value":"1.92","vol":"2.12"},{"date":"2023-09-30","value":"1.94","vol":"2.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.98 | 1.99 | 1.93 | 1.92 | 1.94 |
| 行业(%) | 2.19 | 2.15 | 2.15 | 2.12 | 2.07 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东方证券 | 2024-11-18 | 买入 | |
| 华福证券 | 2024-11-08 | 买入 | 买入 |
| 兴业证券 | 2024-11-08 | 增持 | |
| 中信建投证券 | 2024-11-07 | 买入 | 买入 |
| 东吴证券 | 2024-11-06 | 买入 | |
| 浙商证券 | 2024-11-03 | 增持 | 增持 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"44.96","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"50.93","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"56.17","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"37.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"50.76","blueLineValue":"1.37","type":"YC"}]